IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 52, Issue 3, 2015, Pages 365-376

  Lee, Jin Hwa ^a   Cho, Michael H ^a,b   Hersh, Craig P ^a,b   McDonald, Merry Lynn N ^a   Wells, J Michael ^c,d   Dransfield, Mark T ^c,d   Bowler, Russell P ^e   Lynch, David A ^e   Lomas, David A ^f   Crapo, James D ^e   Silverman, Edwin K ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Ewha Womans University   (South Korea)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Genome wide association; Pulmonary hypertension; Subtyping

Indexed keywords

GALACTOSYLCERAMIDASE; IRON REGULATORY PROTEIN 2;

ADULT; AORTA; ARTICLE; CHROMOSOME 15Q; CHROMOSOME 15Q25.1; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EFFECT SIZE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIDDLE AGED; PULMONARY ARTERY; PULMONARY ARTERY ENLARGEMENT; PULMONARY VASCULAR DISEASE; QUANTITATIVE TRAIT LOCUS; RISK FACTOR; SECONDARY ANALYSIS; SINGLE BLIND PROCEDURE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPIROMETRY; ADVERSE EFFECTS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY HYPERTENSION;

FEMALE; GALACTOSYLCERAMIDASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; IRON REGULATORY PROTEIN 2; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84924163096     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0210OC     Document Type: Article

References (56)

1. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013; 310:591-608.
2. Patel BD, Coxson HO, Pillai S.G., Agustí AG, Calverley PM, Donner CF, Make BJ, Müller NL, Rennard SI, Vestbo J, et al.; International COPD Genetics Network. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178:500-505.
3. McCloskey SC, Patel BD, Hinchliffe S.J., Reid ED, Wareham NJ, Lomas DA. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001; 164:1419-1424.
4. Silverman EK, Mosley JD, Palmer L.J., Barth M., Senter JM, Brown A, Drazen JM, Kwiatkowski D.J., Chapman HA, Campbell EJ, et al. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum Mol Genet 2002; 11:623-632.
5. Hallberg J, Dominicus A, Eriksson U.K., Gerhardsson de Verdier M, Pedersen NL, Dahlbäck M, Nihlén U, Higenbottam T, Svartengren M. Interaction between smoking and genetic factors in the development of chronic bronchitis. Am J Respir Crit Care Med 2008; 177:486-490.
6. Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 2010; 137(6 suppl):39S-51S.
7. Thabut G, Dauriat G, Stern J.B., Logeart D., Lévy A, Marrash-Chahla R, Mal H. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127:1531-1536.
8. Chaouat A, Bugnet AS, Kadaoui N, Schott R., Enache I, Ducoloné A, Ehrhart M, Kessler R, Weitzenblum E. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:189-194.
9. Santos S, Peinado VI, Ramírez J, Melgosa T., Roca J, Rodriguez-Roisin R, Barberà JA. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 2002; 19:632-638.
10. Christensen CC, Ryg MS, Edvardsen A, Skjønsberg OH. Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients. Eur Respir J 2004; 24:580-586.
11. McGhan R, Radcliff T, Fish R., Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007; 132:1748-1755.
12. Burrows B, Kettel LJ, Niden A.H., Rabinowitz M., Diener CF. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med 1972; 286:912-918.
13. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis 1979; 119:895-902.
14. Oswald-Mammosser M, Weitzenblum E, Quoix E., Moser G, Chaouat A, Charpentier C., Kessler R. Prognostic factors in COPD patients receiving long-term oxygen therapy: importance of pulmonary artery pressure. Chest 1995; 107:1193-1198.
15. Devaraj A, Wells AU, Meister M.G., Corte TJ, Wort SJ, Hansell DM. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology 2010; 254: 609-616.
16. Pérez-Enguix D, Morales P, Tomás JM, Vera F, Lloret RM. Computed tomographic screening of pulmonary arterial hypertension in candidates for lung transplantation. Transplant Proc 2007; 39: 2405-2408.
17. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999; 14:270-278.
18. Iyer AS, Wells JM, Vishin S, Bhatt S.P., Wille KM, Dransfield MTCT. CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest 2014; 145:824-832.
19. Wells JM, Washko GR, Han M.K., Abbas N., Nath H, Mamary AJ, Regan E, Bailey W.C., Martinez FJ, Westfall E, et al.; COPDGene Investigators; ECLIPSE Study Investigators. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 2012; 367:913-921.
20. Vestbo J, Anderson W, Coxson H.O., Crim C., Dawber F, Edwards L, Hagan G., Knobil K, Lomas DA, MacNee W, et al.; ECLIPSE investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008; 31: 869-873.
21. Regan EA, Hokanson JE, Murphy J.R., Make B., Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic Epidemiology of COPD (COPDGene) study design. COPD 2010; 7:32-43.
22. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347-365.
23. Cho MH, McDonald ML, Zhou X, Mattheisen M., Castaldi PJ, Hersh CP, Demeo DL, Sylvia J.S., Ziniti J., Laird NM, et al.; NETT Genetics, ICGN, ECLIPSE and COPDGene Investigators. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med 2014; 2: 214-225.
24. Li Y, Willer CJ, Ding J, Scheet P., Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010; 34:816-834.
25. Howie B, Fuchsberger C, Stephens M., Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012; 44: 955-959.
26. Abecasis GR, Auton A, Brooks L.D., DePristo MA, Durbin RM, Handsaker RE, Kang H.M., Marth GT, McVean GA; 1, 000 Genomes Project Consortium. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012; 491:56-65.
27. Cho MH, Boutaoui N, Klanderman B.J., Sylvia JS, Ziniti JP, Hersh CP, DeMeo D.L., Hunninghake GM, Litonjua AA, Sparrow D, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010; 42:200-202.
28. Kong X, Cho MH, Anderson W, Coxson H.O., Muller N., Washko G, Hoffman EA, Bakke P, Gulsvik A., Lomas DA, et al.; ECLIPSE Study NETT Investigators. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med 2011; 183:43-49.
29. Cho MH, Castaldi PJ, Wan E.S., Siedlinski M., Hersh CP, Demeo DL, Himes BE, Sylvia J.S., Klanderman BJ, Ziniti JP, et al.; ICGN Investigators; ECLIPSE Investigators; COPDGene Investigators. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet 2012; 21:947-957.
30. Purcell S, Neale B, Todd-Brown K, Thomas L., Ferreira MA, Bender D, Maller J, Sklar P., de Bakker PI, Daly MJ, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
31. de Bakker PI, Ferreira MA, Jia X, Neale B.M., Raychaudhuri S., Voight BF. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 2008; 17: R122-R128.
32. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010; 26:2190-2191.
33. Higgins JP, Thompson SG, Deeks J.J., Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
34. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55:997-1004.
35. Aulchenko YS, Ripke S, Isaacs A., van Duijn CM. GenABEL: an R library for genome-wide association analysis. Bioinformatics 2007; 23: 1294-1296.
36. Pruim RJ, Welch RP, Sanna S, Teslovich T.M., Chines PS, Gliedt TP, Boehnke M, Abecasis G.R., Willer CJ. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26:2336-2337.
37. Pillai SG, Ge D, Zhu G., Kong X, Shianna KV, Need A.C., Feng S., Hersh CP, Bakke P, Gulsvik A, et al.; ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5: e1000421.
38. Wilk JB, Shrine NR, Loehr L.R., Zhao JH, Manichaikul A, Lopez LM, Smith A.V., Heckbert SR, Smolonska J, Tang W, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 2012; 186:622-632.
39. Siedlinski M, Tingley D, Lipman P.J., Cho MH, Litonjua AA, Sparrow D, Bakke P., Gulsvik A, Lomas DA, Anderson W, et al.; COPDGene and ECLIPSE Investigators. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum Genet 2013; 132:431-441.
40. Qiu W, Cho MH, Riley J.H., Anderson WH, Singh D, Bakke P, Gulsvik A., Litonjua AA, Lomas DA, Crapo JD, et al.; ECLIPSE Investigators. Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One 2011; 6:e24395.
41. Zhou H, Yang J, Li D., Xiao J, Wang B, Wang L., Ma C, Xu S, Ou X, Feng Y. Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population. J Hum Genet 2012; 57:738-746.
42. Rouault TA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2006; 2:406-414.
43. Rouault T, Klausner R. Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul 1997; 35:1-19.
44. Hanson ES, Foot LM, Leibold EA. Hypoxia post-translationally activates iron-regulatory protein 2. J Biol Chem 1999; 274:5047-5052.
45. Vashisht AA, Zumbrennen KB, Huang X, Powers D.N., Durazo A., Sun D, Bhaskaran N, Persson A., Uhlen M, Sangfelt O, et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 2009; 326:718-721.
46. Salahudeen AA, Thompson JW, Ruiz J.C., Ma HW, Kinch LN, Li Q, Grishin N.V., Bruick RK. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 2009; 326:722-726.
47. Debs R, Froissart R, Aubourg P., Papeix C, Douillard C, Degos B., Fontaine B, Audoin B, Lacour A, Said G, et al. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherit Metab Dis 2013; 36:859-868.
48. Belleri M, Ronca R, Coltrini D., Nico B, Ribatti D, Poliani P.L., Giacomini A., Alessi P, Marchesini S, Santos MB, et al. Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy. Brain 2013; 136:2859-2875.
49. Petrache I, Natarajan V, Zhen L., Medler TR, Richter AT, Cho C, Hubbard W.C., Berdyshev EV, Tuder RM. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005; 11:491-498.
50. Petrache I, Petrusca DN, Bowler R.P., Kamocki K. Involvement of ceramide in cell death responses in the pulmonary circulation. Proc Am Thorac Soc 2011; 8:492-496.
51. Clarke JT, Ozere RL, Krause VW. Early infantile variant of Krabbe globoid cell leucodystrophy with lung involvement. Arch Dis Child 1981; 56:640-642.
52. DeMeo DL, Mariani T, Bhattacharya S., Srisuma S, Lange C, Litonjua A., Bueno R, Pillai SG, Lomas DA, Sparrow D, et al. Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet 2009; 85:493-502.
53. Lam CS, Borlaug BA, Kane G.C., Enders FT, Rodeheffer RJ, Redfield MM. Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 2009; 119:2663-2670.
54. Barberà JA, Riverola A, Roca J, Ramirez J, Wagner PD, Ros D, Wiggs BR, Rodriguez-Roisin R. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149: 423-429.
55. Barr RG, Bluemke DA, Ahmed F.S., Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut S.M., Kronmal RA, Lima JA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362:217-227.
56. Matsuoka S, Washko GR, Yamashiro T, Estepar R.S., Diaz A., Silverman EK, Hoffman E, Fessler HE, Criner G.J., Marchetti N., et al.; National Emphysema Treatment Trial Research Group. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med 2010; 181:218-225.